相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia
Mohamed A. Helal et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis
Li-Mei Wang et al.
RHEUMATOLOGY (2022)
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis
Susumu Sakamoto et al.
SCIENTIFIC REPORTS (2022)
Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
Xia Lv et al.
FRONTIERS IN MEDICINE (2022)
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
Giacomo Sgalla et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Multiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis
Ana P. M. Serezani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)
The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study
Yuji Nishimoto et al.
JOURNAL OF CARDIOLOGY (2022)
Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis
Corina N. D'Alessandro-Gabazza et al.
NATURE COMMUNICATIONS (2022)
Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease
Myeong Geun Choi et al.
SCIENTIFIC REPORTS (2022)
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
Jean-Marc Naccache et al.
LANCET RESPIRATORY MEDICINE (2022)
Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel
Matan J. Cohen et al.
JAMA NETWORK OPEN (2022)
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
Noriyuki Enomoto et al.
BMC PULMONARY MEDICINE (2022)
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022
Stacey Adjei et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Management of COVID-19: A comprehensive and practical approach
M.S. Barthwal et al.
Medical Journal Armed Forces India (2022)
Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease
Shengnan Zhao et al.
MODERN RHEUMATOLOGY (2022)
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
Hironao Hozumi et al.
RESPIRATORY RESEARCH (2022)
Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease
Takahisa Gono et al.
RHEUMATOLOGY (2022)
COVID-19 and acute exacerbation of interstitial lung disease
Yasuhiro Kondoh et al.
RESPIRATORY INVESTIGATION (2021)
Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis
Kazuki Tanaka et al.
RESPIRATORY INVESTIGATION (2021)
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki et al.
CELL (2021)
Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage: Predictive Role for Acute Exacerbation of Idiopathic Interstitial Pneumonias
Toru Arai et al.
CANADIAN RESPIRATORY JOURNAL (2021)
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury
Kai Erik Swenson et al.
CRITICAL CARE CLINICS (2021)
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Kevin Shenderov et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Silent hypoxaemia in COVID-19 patients
Tatum S. Simonson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians
Sabrina Setembre Batah et al.
RESPIRATORY MEDICINE (2021)
Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms
Takuya Noguchi et al.
CELL DEATH & DISEASE (2021)
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu et al.
CELL (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
Felice D'Agnillo et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Elizabeth A. Thompson et al.
CELL REPORTS (2021)
Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features
Anastasia Gangaev et al.
NATURE COMMUNICATIONS (2021)
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
Yasuhiro Kondoh et al.
RESPIRATORY INVESTIGATION (2021)
Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Hiroshige Shimizu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury
Astrid Obermayer et al.
DISEASE MARKERS (2021)
Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease
Masato Kono et al.
RESPIRATORY MEDICINE (2021)
Mechanisms of gefitinib-induced interstitial pneumonitis: why and how the TKI perturbs innate immune systems?
Tomohiro Kagi et al.
Oncotarget (2021)
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
Mari Terada et al.
BMJ OPEN (2021)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial
Vincent C. Marconi et al.
LANCET RESPIRATORY MEDICINE (2021)
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
Annamaria Paolini et al.
CELLS (2021)
COVID-19 pneumonia: current evidence of chest imaging features, evolution and prognosis
Anna Rita Larici et al.
CHINESE JOURNAL OF ACADEMIC RADIOLOGY (2021)
COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes
William Bain et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Management of Myositis-Associated Interstitial Lung Disease
Tomoyuki Fujisawa
MEDICINA-LITHUANIA (2021)
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial
Tomoyuki Fujisawa et al.
RESPIROLOGY (2021)
Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis
Kakuhiro Yamaguchi et al.
RESPIROLOGY (2020)
Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial
Kazuki Takada et al.
RHEUMATOLOGY (2020)
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis
Hideaki Tsuji et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis A Randomized, Double-Blind Placebo-controlled Trial
Yasuhiro Kondoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia
Tae Iwasawa et al.
JAPANESE JOURNAL OF RADIOLOGY (2020)
Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment
Mirei Shirakashi et al.
RHEUMATOLOGY (2020)
A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis
Corina N. D'Alessandro-Gabazza et al.
NATURE COMMUNICATIONS (2020)
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Hua Su et al.
KIDNEY INTERNATIONAL (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population
Manuel A. Torres Acosta et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Aymeric Silvin et al.
CELL (2020)
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells
Yujie Ren et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
David Ellinghaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia
Lara Gibellini et al.
EMBO MOLECULAR MEDICINE (2020)
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection
Benedetta Peruzzi et al.
IMMUNOLOGY (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis: a propensity score matching analysis
Jieun Kang et al.
SCIENTIFIC REPORTS (2020)
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation
Shufen Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
Naoshi Nishina et al.
RMD OPEN (2020)
Pulmonary Vascular Manifestations of COVID-19 Pneumonia
Min Lang et al.
RADIOLOGY-CARDIOTHORACIC IMAGING (2020)
Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
Hideta Nakamura et al.
CRITICAL CARE (2020)
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
Noriyuki Enomoto et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
Yong Xiong et al.
EMERGING MICROBES & INFECTIONS (2020)
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
I-Yin Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease
Tomoyuki Fujisawa et al.
JOURNAL OF RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD
Yasuoki Horiike et al.
RHEUMATOLOGY (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis
Noriyuki Enomoto et al.
SCIENTIFIC REPORTS (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis
Noriyuki Enomoto et al.
CLINICAL RESPIRATORY JOURNAL (2018)
Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC
Chong Hyun Suh et al.
LUNG CANCER (2018)
Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis
Noriyuki Enomoto et al.
CHRONIC RESPIRATORY DISEASE (2018)
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
Yumiko Sugiyama et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
Harold R. Collard et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The endothelium in hypoxic pulmonary vasoconstriction
Benjamin Grimmer et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease
Hironao Hozumi et al.
JOURNAL OF RHEUMATOLOGY (2017)
Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia
Haruhiko Furusawa et al.
RESPIROLOGY (2017)
Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies
Fang Chen et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
Katsuhiro Oda et al.
SCIENTIFIC REPORTS (2017)
Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease
Yasunori Enomoto et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Roles of Periostin in Respiratory Disorders
Kenji Izuhara et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Radiological and Pathological Correlation in Anti-MDA5 Antibody-positive Interstitial Lung Disease: Rapidly Progressive Perilobular Opacities and Diffuse Alveolar Damage
Haruka Chino et al.
INTERNAL MEDICINE (2016)
Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis
Keiji Oishi et al.
INTERNAL MEDICINE (2016)
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease
Hironao Hozumi et al.
RESPIRATORY MEDICINE (2016)
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Luca Richeldi et al.
RESPIRATORY MEDICINE (2016)
Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
Tomoyuki Kakugawa et al.
RESPIRATORY RESEARCH (2016)
Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue
Qing-Lin Peng et al.
JOURNAL OF RHEUMATOLOGY (2015)
Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
Masayuki Takeda et al.
LUNG CANCER (2015)
Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Jonas Christian Schupp et al.
PLOS ONE (2015)
Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival
Noriyuki Enomoto et al.
BMC PULMONARY MEDICINE (2015)
Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study
Hironao Hozumi et al.
PLOS ONE (2015)
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis - Extended analysis of pirfenidone trial in Japan
Yasuhiro Kondoh et al.
RESPIRATORY INVESTIGATION (2015)
Diverse macrophage populations mediate acute lung inflammation and resolution
Neil R. Aggarwal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences
Motoki Natsuizaka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer
Akihiko Gemma et al.
CANCER SCIENCE (2014)
Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer
Toshihiko Sato et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Diffuse alveolar damage in patients with dermatomyositis: a six-case series
Yuko Matsuki et al.
Modern Rheumatology (2014)
Prognostic Factors for Myositis-Associated Interstitial Lung Disease
Tomoyuki Fujisawa et al.
PLOS ONE (2014)
Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease
Takahisa Gono et al.
RHEUMATOLOGY (2014)
Myositis autoantibodies and clinical phenotypes
Anna Ghirardello et al.
AUTOIMMUNITY HIGHLIGHTS (2014)
Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis
Keishi Oda et al.
RESPIRATORY RESEARCH (2014)
Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses
Rehan A. Kahloon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The Hyperferritinemic Syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome
Cristina Rosario et al.
BMC MEDICINE (2013)
A Protective Hsp70-TLR4 Pathway in Lethal Oxidant Lung Injury
Yi Zhang et al.
JOURNAL OF IMMUNOLOGY (2013)
The prognostic value of HRCT in myositis-associated interstitial lung disease
Kiminobu Tanizawa et al.
RESPIRATORY MEDICINE (2013)
Acute exacerbations in patients with idiopathic pulmonary fibrosis
Dong Soon Kim
RESPIRATORY RESEARCH (2013)
The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
Riitta Kaarteenaho
RESPIRATORY RESEARCH (2013)
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
Harold R. Collard et al.
RESPIRATORY RESEARCH (2013)
Consensus statement for the diagnosis and treatment of drug-induced lung injuries
Keishi Kubo et al.
RESPIRATORY INVESTIGATION (2013)
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
J. S. Lee et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Polymyxin B-immobilized Fiber Column (PMX) Treatment for Idiopathic Pulmonary Fibrosis with Acute Exacerbation: A Multicenter Retrospective Analysis
Shinji Abe et al.
INTERNAL MEDICINE (2012)
Interstitial lung disease in connective tissue disorders
Aryeh Fischer et al.
LANCET (2012)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Outcome and Prognostic Factors
Virginie Simon-Blancal et al.
RESPIRATION (2012)
Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures
Koji Sakamoto et al.
RESPIRATORY MEDICINE (2012)
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM
Tomohiro Koga et al.
RHEUMATOLOGY (2012)
Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM
Takahisa Gono et al.
RHEUMATOLOGY (2012)
Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis
Teluguakula Narasaraju et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Evaluation of Different Perfusion Durations in Direct Hemoperfusion with Polymyxin B-Immobilized Fiber Column Therapy for Acute Exacerbation of Interstitial Pneumonias
Masato Kono et al.
BLOOD PURIFICATION (2011)
Reduction in Serum High Mobility Group Box-1 Level by Polymyxin B-Immobilized Fiber Column in Patients with Idiopathic Pulmonary Fibrosis with Acute Exacerbation
Shinji Abe et al.
BLOOD PURIFICATION (2011)
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J. W. Song et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
Hideto Kameda et al.
INTERNAL MEDICINE (2011)
Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan
Yoshioki Yamasaki et al.
JOURNAL OF RHEUMATOLOGY (2011)
Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis
Takushi Namba et al.
PLOS ONE (2011)
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody
Kiminobu Tanizawa et al.
RESPIRATORY MEDICINE (2011)
Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan
Yoshinao Muro et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Masahito Ebina et al.
PULMONARY MEDICINE (2011)
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis
Harold R. Collard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Neutrophil Adsorption by Polymyxin B-Immobilized Fiber Column for Acute Exacerbation in Patients with Interstitial Pneumonia: A Pilot Study
Shinji Abe et al.
BLOOD PURIFICATION (2010)
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody
Ran Nakashima et al.
RHEUMATOLOGY (2010)
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Kei Hoshino et al.
RHEUMATOLOGY (2010)
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2010)
Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA
A. Nakajima et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Antje Prassel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Kazuhisa Konishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
Jan M. Ehrchen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis
Yuzo Suzuki et al.
LUNG (2009)
Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
Takafumi Suda et al.
RESPIRATORY MEDICINE (2009)
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis
Tetsuji Sawada et al.
RHEUMATOLOGY (2009)
Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model
Takayoshi Fujibayashi et al.
BMC Pulmonary Medicine (2009)
Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients
Arata Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis
Masanori Akira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
Shoji Kudoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
High-resolution computed tomography patterns and immunopathogenetic findings in drug-induced pneumonitis
Keiko Takatani et al.
RESPIRATORY MEDICINE (2008)
Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia
Noriyuki Enomoto et al.
RESPIROLOGY (2008)
Acute exacerbations of idiopathic pulmonary fibrosis
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis
I-Nae Park et al.
CHEST (2007)
Prognosis of fibrotic interstitial pneumonia - Idiopathic versus collagen vascular disease-related subtypes
Joo Hun Park et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Interstitial lung diseases associated with amyopathic dermatomyositis
T. Suda et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Acute exacerbation of interstitial pneumonia following surgical lung biopsy
Yasuhiro Kondoh et al.
RESPIRATORY MEDICINE (2006)
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
DS Kim et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis
TT Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Circulating KL-6 levels in patients with drug induced pneumonitis
H Ohnishi et al.
THORAX (2003)
Severe acute interstitial pneumonia and gefitinib
A Inoue et al.
LANCET (2003)